Document Detail


Antiretroviral therapy, labor productivity, and sex: a longitudinal cohort study of tea pluckers in Kenya.
MedLine Citation:
PMID:  23014516     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To estimate the impact of antiretroviral therapy (ART) on labor productivity and income using detailed employment data from two large tea plantations in western Kenya for HIV-infected tea pluckers who initiated ART.
DESIGN: Longitudinal study using primary data on key employment outcomes for a group of HIV-infected workers receiving antiretroviral therapy (ART) and workers in the general workforce.
METHODS: We used nearest-neighbor matching methods to estimate the impacts of HIV/AIDS and ART among 237 HIV-positive pluckers on ART (index group) over a 4-year period (2 years pre-ART and post-ART) on 4 monthly employment outcomes - days plucking tea, total kilograms (kgs) harvested, total days working, and total labor income. Outcomes for the index group were compared with those for a matched reference group from the general workforce.
RESULTS: We observed a rapid deterioration in all four outcomes for HIV-infected individuals in the period before ART initiation and then a rapid improvement after treatment initiation. By 18-24 months after treatment initiation, the index group harvested 8% (men) and 19% (women) less tea than reference individuals. The index group earned 6% (men) and 9% (women) less income from labor than reference individuals. Women's income would have dropped further if they had not been able to offset their decline in tea plucking by spending more time on nonplucking assignments.
CONCLUSION: HIV-infected workers experienced long-term income reductions before and after initiating ART. The implications of such long-term impacts in low-income countries have not been adequately addressed.
Authors:
Bruce A Larson; Matthew P Fox; Margaret Bii; Sydney Rosen; Julia Rohr; Douglas Shaffer; Fredrick Sawe; Monique Wasunna; Jonathon L Simon
Related Documents :
25119896 - Haplotype analysis of interleukin-10 gene promoter polymorphisms in chronic hepatitis c...
23469586 - Epidemiological and clinical characteristics and behaviours of individuals with newly d...
23086426 - Hiv-positive and in jail: race, risk factors, and prior access to care.
12591756 - Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunolog...
8192176 - Tuberculosis and acquired immunodeficiency syndrome: a historical perspective on recent...
17497016 - Antihuman immunodeficiency virus type 1 (hiv-1) activity of rare earth metal complexes ...
Publication Detail:
Type:  Comparative Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  AIDS (London, England)     Volume:  27     ISSN:  1473-5571     ISO Abbreviation:  AIDS     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2012-12-12     Completed Date:  2013-06-17     Revised Date:  2014-07-03    
Medline Journal Info:
Nlm Unique ID:  8710219     Medline TA:  AIDS     Country:  England    
Other Details:
Languages:  eng     Pagination:  115-23     Citation Subset:  IM; X    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Absenteeism
Acquired Immunodeficiency Syndrome / drug therapy,  economics,  epidemiology*
Adult
Agriculture*
Anti-HIV Agents / economics,  therapeutic use*
CD4 Lymphocyte Count
Cohort Studies
Efficiency*
Employment
Female
HIV Seropositivity / drug therapy,  economics,  epidemiology*
Humans
Income
Kenya / epidemiology
Longitudinal Studies
Male
Middle Aged
Policy Making
Sex Distribution
Tea*
Work*
Workload / economics
Grant Support
ID/Acronym/Agency:
5R01TW7181-3/TW/FIC NIH HHS; R01 TW007181/TW/FIC NIH HHS
Chemical
Reg. No./Substance:
0/Anti-HIV Agents; 0/Tea
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mesoporous nanomagnet supercaptors for selective heme-proteins from human cells.
Next Document:  Cost and outcomes of paediatric antiretroviral treatment in South Africa.